Loading...
Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure
BACKGROUND: High rates of HBeAg and/or HBsAg seroconversion or clearance have been achieved in chronic hepatitis B (CHB) patients receiving pegylated interferon (pegIFN) in addition to ongoing nucleos(t)ide analogue (NUC) treatment. In the present study, we aimed to evaluate HBsAg kinetics to predic...
Na minha lista:
| Udgivet i: | Med Sci Monit |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
International Scientific Literature, Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6604672/ https://ncbi.nlm.nih.gov/pubmed/31230063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.916441 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|